Results 131 to 140 of about 1,874,188 (207)

[Travellers' compliance with the use of an oral cholera vaccine].

, 2010
A questionnaire study was performed amongst subjects travelling to high-risk areas for traveller's diarrhoea and who had been prescribed the oral cholera vaccine Dukoral.
BURIANI, Orazio, GABUTTI, Giovanni, SERENELLI, Carlotta, Ghiselli G., CUCCHI, Alessandro, Merciadri G.V., COVA, Marisa   +6 more
core  

A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries. [PDF]

BMC Public Health, 2023
Trolle H, Forsberg B, King C, Akande O, Ayres S, Alfvén T, Elimian K.   +6 more
europepmc   +1 more source

Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera

, 1998
Recent large epidemics of cholera with high incidence and associated mortality among refugees have raised the question of whether oral cholera vaccines should be considered as an additional preventive measure in high- risk populations.
Murray, J., Waldman, R. J., McFarland, D. A.   +2 more
core  

Lessons learned from the deployment of oral cholera vaccine by maintaining the controlled temperature chain (CTC) in an urban setting, Bangladesh. [PDF]

Hum Vaccin Immunother
Islam MT, Khan AI, Khan ZH, Amin MA, Shahnaz S, Sultana QF, Bhuiyan MTR, Rimal A, Robertson J, Kahn AL, Qadri F.   +10 more
europepmc   +1 more source

Pre-vaccination biomarkers of enteric dysfunction, inflammation and nutritional status associate with seroconversion to oral cholera vaccine and are perturbed during natural infection. [PDF]

Front Immunol
Liswaniso F, Phiri B, Chibuye M, Luchen CC, Ngosa D, Ng'ombe H, Chibesa K, Muchimba M, Chilengi R, Bosomprah S, Chisenga CC.   +10 more
europepmc   +1 more source

Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol™) in adults residing in Lukanga Swamps of Zambia. [PDF]

PLoS One, 2022
Ng Ombe H, Simuyandi M, Mwaba J, Luchen CC, Alabi P, Chilyabanyama ON, Mubanga C, Hatyoka LM, Muchimba M, Bosomprah S, Chilengi R, Kwenda G, Chisenga CC.   +12 more
europepmc   +1 more source

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference. [PDF]

Clin Infect Dis, 2023
Islam MT, Date K, Khan AI, Bhuiyan TR, Khan ZH, Ahmed S, Hossain M, Khaton F, Zaman K, McMillan NAJ, Anand A, An Q, Zhang C, Weldon WC, Yu A, Luby S, Qadri F.   +16 more
europepmc   +1 more source

Strategies for achieving a healthy oral cholera vaccine market: Model-enabled scenario exploration of supply and demand dynamics. [PDF]

PLoS Negl Trop Dis
Guttieres D, Van Riet C, Vandaele N, Decouttere C.   +3 more
europepmc   +1 more source

Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigens. [PDF]

Nat Commun
Chac D, Heller FJ, Banna HA, Kaisar MH, Markiewicz SM, Pruitt EL, Chowdhury F, Bhuiyan TR, Akter A, Khan AI, Dumayas MG, Rice A, Karmakar PC, Dash P, LaRocque RC, Ryan ET, Xu L, Minot SS, Harris JB, Qadri F, Weil AA.   +20 more
europepmc   +1 more source

Dissecting serotype-specific contributions to live oral cholera vaccine efficacy. [PDF]

Proc Natl Acad Sci U S A, 2021
Sit B, Fakoya B, Zhang T, Billings G, Waldor MK.   +4 more
europepmc   +1 more source